In a notable transfer, the Federal Commerce Fee put drugmakers and pharmacy profit managers on discover that the company will “ramp up enforcement” of any “unlawful bribes and rebate schemes” that make it more durable for sufferers to entry lower-cost medicines.
The brand new policy statement famous the FTC plans to scrutinize rebates and various charges for indicators that these funds are violating antitrust and client safety legal guidelines. As a part of that effort, the company expects to observe lawsuits and file its personal authorized briefs in instances the place it could possibly present help in analyzing unlawful practices that will increase prescription drug costs.
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
